HER2-targeting chimeric antigen receptor myeloid cells derived from expanded cord blood hematopoietic stem and progenitor cells for ovarian cancer immunotherapy
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2211014
- Recipient
-
Immunebridge Inc. UEI KNRHGAGETGM9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $301,279
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- San Francisco, CA 94110, USA
Award details come from USAspending.gov.
Quick answers
Who received award W81XWH2211014?
W81XWH2211014 was awarded to Immunebridge Inc. by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2211014 worth?
$301,279 has been obligated on W81XWH2211014.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award